TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
3759 Stock 12 Month Forecast
There Are No Analyst Ratings for HK:3759 In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
3759 Financial Forecast
3759 Earnings Forecast
Next quarter’s earnings estimate for 3759 is HK$0.31 with a range of HK$0.30 to HK$0.33. The previous quarter’s EPS was HK$0.27. 3759 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year 3759 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 3759 is HK$0.31 with a range of HK$0.30 to HK$0.33. The previous quarter’s EPS was HK$0.27. 3759 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year 3759 has Performed in-line its overall industry.
3759 Sales Forecast
Next quarter’s sales forecast for 3759 is HK$4.48B with a range of HK$4.48B to HK$4.48B. The previous quarter’s sales results were HK$3.98B. 3759 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year 3759 has Performed in-line its overall industry.
Next quarter’s sales forecast for 3759 is HK$4.48B with a range of HK$4.48B to HK$4.48B. The previous quarter’s sales results were HK$3.98B. 3759 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year 3759 has Performed in-line its overall industry.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Unknown Analyst
CLSA
Not Ranked
CLSA
HK$24.7→HK$28.8
Buy
19.30%
Upside
Reiterated
10/30/25
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
HK$26.6→HK$30
Buy
24.28%
Upside
Reiterated
10/30/25
Pharmaron Beijing Co., Ltd. Class H (17Q1) Receives a Buy from Goldman Sachs
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +0.80% per trade.
Copying Ruili Bian's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -10.70% per trade.
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -10.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
3759 Analyst Recommendation Trends
Rating
Sep 25
Oct 25
Dec 25
Jan 26
Feb 26
Strong Buy
12
17
8
10
5
Buy
2
0
0
0
0
Hold
1
0
1
10
14
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
17
9
20
19
In the current month, 3759 has received 5Buy Ratings, 14Hold Ratings, and 0Sell Ratings. 3759 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
3759 Stock Forecast FAQ
What is HK:3759’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:3759’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:3759, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Pharmaron Beijing Co., Ltd. Class H a Buy, Sell or Hold?
Currently, no data Available
What is Pharmaron Beijing Co., Ltd. Class H’s share price target?
Currently, no data Available
What do analysts say about Pharmaron Beijing Co., Ltd. Class H?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Pharmaron Beijing Co., Ltd. Class H?
To buy shares of HK:3759, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.